317 related articles for article (PubMed ID: 8516938)
1. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
Cramer DV; Chapman FA; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
[TBL] [Abstract][Full Text] [Related]
2. Brequinar sodium.
Cramer DV
Transplant Proc; 1996 Apr; 28(2):960-3. PubMed ID: 8623481
[TBL] [Abstract][Full Text] [Related]
3. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV
Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706
[TBL] [Abstract][Full Text] [Related]
4. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
[TBL] [Abstract][Full Text] [Related]
5. Brequinar sodium: monitoring immunosuppressive activity.
Eiras-Hreha G; Cramer DV; Cosenza C; Chapman FA; Mills L; Cajulis E; Hill D; Jones E; Zajac I; Jaffee B
Transplant Proc; 1993 Jun; 25(3 Suppl 2):32-6. PubMed ID: 8516940
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L
J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026
[TBL] [Abstract][Full Text] [Related]
7. The development of Brequinar as an immunosuppressive drug for transplantation.
Makowka L; Sher LS; Cramer DV
Immunol Rev; 1993 Dec; 136():51-70. PubMed ID: 8132203
[TBL] [Abstract][Full Text] [Related]
8. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive effect of combination schedules of brequinar with leflunomide or tacrolimus on rat cardiac allotransplantation.
Antoniou EA; Deroover A; Howie AJ; Chondros K; McMaster P; D'Silva M
Microsurgery; 1999; 19(2):98-102. PubMed ID: 10188834
[TBL] [Abstract][Full Text] [Related]
10. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
[TBL] [Abstract][Full Text] [Related]
11. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
Knoop M; Cramer DV; Chapman FC; Makowka L
Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
[No Abstract] [Full Text] [Related]
12. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945
[No Abstract] [Full Text] [Related]
13. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
[No Abstract] [Full Text] [Related]
14. LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model.
Zhou D; O'Brien C; Shum J; Garcia B; Min W; Jevnikar AM; Dutartre P; Zhong R
Transplantation; 2003 Aug; 76(4):644-50. PubMed ID: 12973102
[TBL] [Abstract][Full Text] [Related]
15. The role and value of sirolimus administration in kidney and liver transplantation.
Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
[TBL] [Abstract][Full Text] [Related]
16. Brequinar sodium.
Cramer DV
Pediatr Nephrol; 1995; 9 Suppl():S52-5. PubMed ID: 7492488
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
18. The prolongation of concordant hamster-to-rat cardiac xenografts by brequinar sodium.
Cramer DV; Chapman FA; Jaffee BD; Zajac I; Hreha-Eiras G; Yasunaga C; Wu GD; Makowka L
Transplantation; 1992 Sep; 54(3):403-8. PubMed ID: 1412717
[TBL] [Abstract][Full Text] [Related]
19. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
[TBL] [Abstract][Full Text] [Related]
20. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
